A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Clinical trial NCT06660394 · RECRUITING

Trial details

NCT number: NCT06660394
Sponsor: Longboard Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dravet Syndrome

Start date: 2024-09-25
Primary completion: 2026-08-21
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.